Abstract
Five 1-azaanthraquinone-3-carboxamides were synthesized and evaluated in vitro cytotoxicity against four human cancer cell lines. The most active compound,7b, exhibited cytotoxic activity comparable to doxorubicin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References Cited
Atwell, G. J., Rewcastle, G. W. Baguley, B. C., Denny, W. A., Potential Antitumor Agents. 50. In vivo solid tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.J. Med. Chem., 30, 664–669 (1987).
Baguley, B. C., Zhuang, L., Marshall, E. M., Experimental solid tumor activity ofN-[2-(dimethylamino)ethyl]acridine-4-carboxamide.Cancer Chemother. Pharmacol., 36, 244–248 (1995).
Bonner, J. A., Kozelsky, T. F., The significance of the sequence of administration of topotecan and etoposide.Cancer Chemother. Pharmacol. 39, 109–12 (1996).
Cortes, F., Pinero, J., Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells.Cancer Chemother. Pharmacol., 34, 411–5 (1994).
Ishida, T., Nishio, K., Arioka, H., Kurokawa, H., Fukumoto, H., Fukuoka, K. Nomoto, T., Yokote, H., Saijo, N., TAS-103, a, novel dual inhibitor of DNA topoisomerase I and II.Proc. Am. Assoc. Cancer Res. 37, 428 (abstr. 2922) (1996)
Lee, H., Hong, S-.S. and Kim, Y-. H., Synthesis and In Vitro Evaluation of 3-Substituted-1-azaanthraquinones.Bio. Med. Chem. Lett., 6, 933–936 (1996).
Lee, H., Hong, S-. S., Choi, J-.Y. and Kim, Y-. H., Synthesis and In vitro Evaluation of 4-Substituted-1-azzaanthraquinones.Arch. Pharm. Res., 21, 73–75 (1998).
Lee, H., Choi, J-.Y., Lee, S. I., Hong, S-.S., Cho, J. and Kim, Y-. H., Synthesis and In vitro Cytotoxicity of 3- or 4-Dialkylaminomethyl-1-Azaanthraquinones.Arch. Pharm. Res., 21, 749–752 (1998).
Lee, H., Lee, S. I., Yang, S. I., Synthesis and In Vitro Cytotoxicity of 3-Substituted-1,8-diazaanthraquinones Produced by Regioselective Hetero Diels-Alder Reaction.Bio. Med. Chem. Lett., 8, 2991–2994 (1998).
Luzzio, M. J., Besterman, J. M, Emerson, D. L., Evans, M. G., Lackey, K., Leitner, P.L., Mcintyre, G., Morton, B., Myers, P. L., Peel, M., Sisco, J. M., Sternbach, D. D., Tong, W. Q., Truesdale, A., Uehling, D. E., Vuong, A., Yates, J., Synthesis and Antitumor Activity of Novel Water Soluble Derivatives of Camptothecin as Specific Inhibitors of Topoisomerase I.J. Med. Chem., 38, 395–401 (1995).
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenny, S. and Boyd, M. R., New colorimetric cytotoxicity assay for anticancerdrug screening.J. Natl. Cancer Inst., 82, 1107–1112 (1990).
Utsugi, T., Aoyagi, K., Furune, Y., Sano, M., Wierzba, K., Okazaki, S., Asao, T., Yamada, Y., Antitumor acti-vity of TAS-103, a novel topoisomerase I and II inhibitor.Proc. Am. Assoc. Cancer Res. 37, 427 (abstr. 2815) (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, H., Lee, Cw. & Yang, SI. Synthesis andin vitro cytotoxicity of 1-azaanthraquinone-3-carboxamides. Arch Pharm Res 22, 380–383 (1999). https://doi.org/10.1007/BF02979061
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02979061